Source: European Medicines Agency (EU) Revision Year: 2024 Publisher: Sandoz GmbH, Biochemiestr. 10, 6250 Kundl, Austria
Wyost 120 mg solution for injection.
Pharmaceutical Form |
---|
Solution for injection (injection). Clear to slightly opalescent, colourless to slightly yellowish or slightly brownish solution with a pH between 4.9 and 5.5 and an osmolality of 245–345 mOsmol/kg. |
Each vial contains 120 mg of denosumab in 1.7 mL of solution (70 mg/mL).
Denosumab is a human monoclonal IgG2 antibody produced in a mammalian cell line (Chinese hamster ovary cells) by recombinant DNA technology.
Excipient with known effect: Each 1.7 mL of solution contains 78.9 mg sorbitol (E420).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Denosumab |
Denosumab is a human monoclonal antibody (IgG2) that targets and binds with high affinity and specificity to RANKL, preventing activation of its receptor, RANK, on the surface of osteoclast precursors and osteoclasts. Prevention of the RANKL/RANK interaction inhibits osteoclast formation, function and survival, thereby decreasing bone resorption in cortical and trabecular bone. |
List of Excipients |
---|
Acetic acid, glacial* * Acetate buffer is formed by mixing acetic acid with sodium hydroxide |
1.7 mL solution in a single use vial (type I glass) with stopper (fluoropolymer coated elastomeric) and seal (aluminium) with flip-off cap.
Pack size of one vial.
Sandoz GmbH, Biochemiestr. 10, 6250 Kundl, Austria
EU/1/24/1812/001
Drug | Countries | |
---|---|---|
WYOST | Canada, Lithuania, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.